The first human trials of a coronavirus vaccine have been approved in Germany and the UK.
German regulators have given the green-light to BioNTech and Pfizer's clinical trial of four vaccine candidates in Germany.The first phase of the trial will be conducted on about 200 healthy people between the ages of 18 to 55.
Share





